Analysis Novo Nordisk’s Defensive Posture: A Market Leader Fighting on Multiple Fronts
The chief executive’s choice of words on Friday was telling. “The obesity market is not a zero-sum game,” Mike Doustdar told Reuters, reaching for an analogy from the company’s own...